Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity.
Low
C L
CL
Albany College of Pharmacy, Stratton VA Medical Center, Albany, NY 12208, USA.
Phelps
K R
KR
Bailie
G R
GR
D000120:Acecainide / Q000097:blood / Q000493:pharmacokinetics*; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics*; D001281:Atrial Fibrillation / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000378:metabolism / Q000628:therapy; D006464:Hemoperfusion; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011342:Procainamide / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics*; D006435:Renal Dialysis
D000889:Anti-Arrhythmia Agents; D000120:Acecainide; D011342:Procainamide